About
Chip Diagnostics develops nanoscale liquid biopsy technology based on exosome and extracellular vesicle analysis to enable minimally invasive disease detection, drug efficacy prediction, and patient monitoring with organ-specific disease signatures.
Explore Chip Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.